Parathyroid resistance to FGF23 in kidney transplant recipients: Back to the past or ahead to the future

11Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Fibroblast growth factor 23 (FGF23) modulates the metabolism of minerals and vitamin D. In chronic kidney disease (CKD), this process is disturbed owing to decreased parathyroid expression of FGF23's receptor complex Klotho-FGF receptor 1. In this issue, Krajisnik and colleagues demonstrate that similar alterations occur in parathyroid glands from kidney transplant recipients in association with a decline in allograft function. Is it possible that these data can be extrapolated to general early-stage CKD patients? © 2010 International Society of Nephrology.

Cite

CITATION STYLE

APA

Komaba, H., Koizumi, M., & Fukagawa, M. (2010, November). Parathyroid resistance to FGF23 in kidney transplant recipients: Back to the past or ahead to the future. Kidney International. https://doi.org/10.1038/ki.2010.283

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free